List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/?page=71
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 768,
    "next": "http://api.gregory-ms.com/trials/?page=72",
    "previous": "http://api.gregory-ms.com/trials/?page=70",
    "results": [
        {
            "trial_id": 69,
            "title": "Ocrelizuamb for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.",
            "summary": "<b>Conditions</b>:    Radiologically Isolated Syndrome;   Multiple Sclerosis<br/><b>Interventions</b>:    Drug: Ocrelizumab;   Other: Placebo<br/><b>Sponsors</b>:    Yale University;   Genentech, Inc.<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-07T16:00:00Z",
            "discovery_date": "2021-05-07T11:43:30Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04877457?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 68,
            "title": "A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab",
            "summary": "<b>Condition</b>:    Relapsing Multiple Sclerosis (RMS)<br/><b>Interventions</b>:    Drug: Ofatumumab;   Biological: mRNA COVID-19 vaccine;   Drug: interferon or glatiramer acetate<br/><b>Sponsor</b>:    Novartis Pharmaceuticals<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-07T16:00:00Z",
            "discovery_date": "2021-05-07T11:43:30Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04878211?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 67,
            "title": "Sonification Techniques for Gait Training",
            "summary": "<b>Conditions</b>:    Parkinson Disease;   Stroke;   Multiple Sclerosis<br/><b>Interventions</b>:    Device: Gait rehabilitation with "sonification";   Other: Standard gait rehabilitation (without sonification)<br/><b>Sponsor</b>:    Istituti Clinici Scientifici Maugeri SpA<br/><b>Recruiting</b>",
            "published_date": "2021-05-06T16:00:00Z",
            "discovery_date": "2021-05-06T11:08:31Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04876339?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 66,
            "title": "EMDR for Depressed People With Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Depression<br/><b>Intervention</b>:    Behavioral: Eye Movement Desensitization and Reprocessing - EMDR<br/><b>Sponsors</b>:    Fondazione Don Carlo Gnocchi Onlus;   EMDR Europe;   Catholic University of the Sacred Heart<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-06T16:00:00Z",
            "discovery_date": "2021-05-06T11:08:31Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04875832?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 64,
            "title": "Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes With Suppressive Capacity in MS",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Drug: Ocrelizumab<br/><b>Sponsors</b>:    Dr Recai Turkoglu;   Health Sciences University Istanbul Haydarpaşa Numune Training and Research Hospital<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-05T16:00:00Z",
            "discovery_date": "2021-05-05T10:42:09Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04874597?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 63,
            "title": "From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: Biological sample collection<br/><b>Sponsor</b>:    Nantes University Hospital<br/><b>Recruiting</b>",
            "published_date": "2021-05-05T16:00:00Z",
            "discovery_date": "2021-05-05T10:42:09Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04873492?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 65,
            "title": "Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases",
            "summary": "<b>Conditions</b>:    Stroke;   Multiple Sclerosis;   Parkinson Disease<br/><b>Interventions</b>:    Device: Experimental Group;   Other: Control Group<br/><b>Sponsors</b>:    IRCCS San Camillo, Venezia, Italy;   IRCCS San Raffaele;   Istituti Clinici Scientifici Maugeri SpA;   IRCCS National Neurological Institute "C. Mondino" Foundation;   I.R.C.C.S. Fondazione Santa Lucia<br/><b>Recruiting</b>",
            "published_date": "2021-05-05T16:00:00Z",
            "discovery_date": "2021-05-05T10:42:09Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04874051?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 62,
            "title": "Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Drug: Ofatumumab<br/><b>Sponsor</b>:    Novartis Pharmaceuticals<br/><b>Not yet recruiting</b>",
            "published_date": "2021-05-03T16:00:00Z",
            "discovery_date": "2021-05-03T11:30:09Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04869358?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 61,
            "title": "Validation of a Novel Instrument Task for Assessing Upper Limb",
            "summary": "<b>Condition</b>:    Assessment of Arm and Hand Sensorimotor Functions in Multiple Sclerosis Subjects<br/><b>Intervention</b>:    Other: Assessment of the upper limb (VPIT + PPIT)<br/><b>Sponsors</b>:    Swiss Federal Institute of Technology;   Kliniken Valens<br/><b>Not yet recruiting</b>",
            "published_date": "2021-04-30T16:00:00Z",
            "discovery_date": "2021-04-30T10:48:20Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04868370?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 59,
            "title": "COVID-19 and Multiple Sclerosis Disease Modifying Therapies",
            "summary": "<b>Conditions</b>:    Covid19;   Multiple Sclerosis<br/><b>Intervention</b>:    <br/><b>Sponsor</b>:    Nottingham University Hospitals NHS Trust<br/><b>Enrolling by invitation</b>",
            "published_date": "2021-04-28T16:00:00Z",
            "discovery_date": "2021-04-28T12:01:02Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04863586?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        }
    ]
}